Literature DB >> 19590236

Toll-like receptors and renal disease.

Michael G Robson1.   

Abstract

Toll-like receptors (TLRs) play a central role in the response of both the innate and the adaptive immune system to microbial ligands. There is also evidence that they are stimulated by endogenous ligands. In this review, I discuss evidence that they are important in renal disease. This discussion considers the role of both endogenous and microbial ligands, and also the contribution of TLRs present on leucocytes and on intrinsic renal cells. There is strong evidence of a role for TLR2 and TLR4 in renal ischaemia-reperfusion injury, with the effects probably mediated by endogenous ligands. In systemic lupus erythematosus, stimulation of TLR7 and TLR9 by host-derived nucleic acids is important. TLR7 stimulation exacerbates disease, but the role of TLR9 is complex. I also discuss evidence that they are important in other forms of glomerulonephritis, with evidence derived mainly from experimental models in which exogenous ligands have been administered. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590236     DOI: 10.1159/000228077

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  28 in total

1.  Toll-like receptor 4 stimulation triggers crescentic glomerulonephritis by multiple mechanisms including a direct effect on renal cells.

Authors:  Angela Giorgini; Heather J Brown; Steven H Sacks; Michael G Robson
Journal:  Am J Pathol       Date:  2010-06-21       Impact factor: 4.307

Review 2.  The role of innate immunity in donor organ procurement.

Authors:  Dianne B McKay
Journal:  Semin Immunopathol       Date:  2011-03-23       Impact factor: 9.623

3.  Toll-like receptor 9 enhances nephritogenic immunity and glomerular leukocyte recruitment, exacerbating experimental crescentic glomerulonephritis.

Authors:  Shaun A Summers; Oliver M Steinmetz; Joshua D Ooi; Poh-yi Gan; Kim M O'Sullivan; Kumar Visvanathan; Shizuo Akira; A Richard Kitching; Stephen R Holdsworth
Journal:  Am J Pathol       Date:  2010-09-16       Impact factor: 4.307

4.  The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis.

Authors:  Kristin Moreth; Rebekka Brodbeck; Andrea Babelova; Norbert Gretz; Tilmann Spieker; Jinyang Zeng-Brouwers; Josef Pfeilschifter; Marian F Young; Roland M Schaefer; Liliana Schaefer
Journal:  J Clin Invest       Date:  2010-11-15       Impact factor: 14.808

Review 5.  Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy.

Authors:  C Hu; L Sun; L Xiao; Y Han; X Fu; X Xiong; X Xu; Y Liu; S Yang; F Liu; Y S Kanwar
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 6.  TLR2 and TLR4 in ischemia reperfusion injury.

Authors:  F Arslan; B Keogh; P McGuirk; A E Parker
Journal:  Mediators Inflamm       Date:  2010-06-09       Impact factor: 4.711

Review 7.  Innate immunity in donor procurement.

Authors:  Kitty P Cheung; Sashi G Kasimsetty; Dianne B McKay
Journal:  Curr Opin Organ Transplant       Date:  2013-04       Impact factor: 2.640

8.  Clarithromycin attenuates the expression of monocyte chemoattractant protein-1 by activating toll-like receptor 4 in human mesangial cells.

Authors:  Koji Tsugawa; Tadaatsu Imaizumi; Shojiro Watanabe; Kazushi Tsuruga; Hidemi Yoshida; Hiroshi Tanaka
Journal:  Clin Exp Nephrol       Date:  2016-09-10       Impact factor: 2.801

9.  Tumor necrosis factor-α synergistically enhances polyinosinic-polycytidylic acid-induced toll-like receptor 3 signaling in cultured normal human mesangial cells: possible involvement in the pathogenesis of lupus nephritis.

Authors:  Tadaatsu Imaizumi; Tomomi Aizawa; Ryo Hayakari; Fei Xing; Pengfei Meng; Kazushi Tsuruga; Tomoh Matsumiya; Hidemi Yoshida; Liang Wang; Tetsuya Tatsuta; Hiroshi Tanaka
Journal:  Clin Exp Nephrol       Date:  2014-03-14       Impact factor: 2.801

10.  Kidney Proximal Tubular TLR9 Exacerbates Ischemic Acute Kidney Injury.

Authors:  Sang Jun Han; Hongmei Li; Mihwa Kim; Mark J Shlomchik; H Thomas Lee
Journal:  J Immunol       Date:  2018-06-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.